</sup> O1, </sup> O2, </sup> L3, </sup> B2, </sup> C2, </sup> N2. Comparação do efeito da terapia anti-VEGF (bevacizumab) subconjuntival e tópica na neovascularização corneana experimental. Arq. Bras. Oftalmol. 2014;77(4):209-213. 10.5935/0004-2749.20140054
© 2024 - All rights reserved - Conselho Brasileiro de Oftalmologia
English PDF
Send this article by email
How to cite this article
Submit a comment
Mendeley
Pocket
Share on Facebook
Share on Twitter
Share on Linkedin
Share on WhatsApp
